Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 9
Submit an article Journal homepage
745
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial

I. M. MajerPharmerit International RotterdamThe NetherlandsCorrespondence[email protected]
,
H. GelderblomLeiden University Medical Center LeidenThe Netherlands
,
W. B. van den HoutLeiden University Medical Center LeidenThe Netherlands
,
E. GrayNovartis Pharmaceuticals, Inc FrimleyUK
&
B. G. VerheggenPharmerit International RotterdamThe Netherlands
Pages 1106-1119 | Accepted 21 Jun 2013, Published online: 19 Jul 2013

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.